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stress response profiling platform will allow a high through-
put and time-resolved classification of chemical-induced stress 
responses, thus assisting in the future mechanism-based safety 
assessment of chemicals.
Keywords High-content imaging · DILI · Adaptive stress 
signaling
Abbreviations
ADR  Adverse drug reaction
AOP  Adverse outcome pathway
BAC  Bacterial artificial chromosome
BFA  Brefeldin A
CDDO-Me  Bardoxolone methyl (methyl-2-cyano 
3,12-dioxooleano-1,9-dien-28-oate)
DDR  DNA damage response
DEM  Diethylmaleate
DILI  Drug-induced liver injury
ER-stress  Endoplasmic reticulum stress
IAA  Iodoacetamide
OSR  Oxidative stress response/antioxidant 
pathways
UPR  Unfolded protein response
Tc  Tunicamycin
Tg  Thapsigargin
Introduction
In the past decades, hepatic toxicity has contributed dispro-
portionately to drug withdrawals (Stevens and Baker 2009). 
Nowadays, drug-induced liver injury (DILI) is still notori-
ously difficult to predict in as well preclinical and clinical 
trial settings because of the often idiosyncratic nature. There 
is a strong incentive to integrate human-relevant mechanistic 
Abstract Adaptive cellular stress responses are paramount in 
the healthy control of cell and tissue homeostasis and gener-
ally activated during toxicity in a chemical-specific manner. 
Here, we established a platform containing a panel of distinct 
adaptive stress response reporter cell lines based on BAC-
transgenomics GFP tagging in HepG2 cells. Our current panel 
of eleven BAC-GFP HepG2 reporters together contains (1) 
upstream sensors, (2) downstream transcription factors and (3) 
their respective target genes, representing the oxidative stress 
response pathway (Keap1/Nrf2/Srxn1), the unfolded protein 
response in the endoplasmic reticulum (Xbp1/Atf4/BiP/Chop) 
and the DNA damage response (53bp1/p53/p21). Using auto-
mated confocal imaging and quantitative single-cell image 
analysis, we established that all reporters allowed the time-
resolved, sensitive and mode-of-action-specific activation 
of the individual BAC-GFP reporter cell lines as defined by 
a panel of pathway-specific training compounds. Implement-
ing the temporal pathway activity information increased the 
discrimination of training compounds. For a set of >30 hepa-
totoxicants, the induction of Srxn1, BiP, Chop and p21 BAC-
GFP reporters correlated strongly with the transcriptional 
responses observed in cryopreserved primary human hepato-
cytes. Together, our data indicate that a phenotypic adaptive 
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understanding of adverse drug reactions in in vitro-based 
data for evidence and read across based on approaches for 
risk assessment. Transcriptomics has contributed much to 
our mechanistic understanding and has helped to initiate and 
populate the adverse outcome pathway (AOP) framework 
(Ankley et al. 2010; Vinken 2013). AOPs are described as 
a sequential chain of causally linked events at different lev-
els of biological organization that together culminate in the 
adverse health outcome. While some AOPs have so far been 
established, a next important step is to translate AOP-related 
mechanistic understanding in advanced, preferably quantita-
tive, high throughput assays that reflect pathways essential 
in target organ toxicity. Our vision is to establish an imag-
ing-based platform that can quantitatively assess the activa-
tion of individual key events relevant to AOPs. Our initial 
focus is on adaptive stress response pathways, which are 
typically part of AOPs and related to adverse drug reactions.
Chemicals may interact with cellular components, lead-
ing to an altered cell biochemical status. Cells sense these 
biochemical changes and activate specific adaptive stress 
response pathways. These pathways are activated to com-
bat detrimental conditions under which cells cannot func-
tion normally. Classical adaptive stress response pathways 
are the antioxidant pathways (OSR) mediated by activa-
tion of the Nrf2 transcriptional program (Venugopal and 
Jaiswal 1998), the endoplasmic reticulum (ER) unfolded 
protein response (UPR) mediated by Xbp1, Atf4 and Atf6 
transcription factor activation (Kim et al. 2006), and the 
DNA damage response (DDR) pathway typically related to 
activation of the p53 (TP53) transcriptional program (Gir-
insky et al. 1995; Reed et al. 1995). We propose that the 
quantitative dynamic monitoring of the activation of these 
adaptive stress response pathways at the single-cell level in 
high throughput systems will significantly contribute on the 
hand to chemical safety assessment.
All the above-mentioned adaptive stress response path-
ways can roughly be conceived as three consecutive steps: 
(1) ‘sensing’ of the biochemical perturbations; (2) down-
stream transcription factor activation through either stabi-
lization and/or nuclear translocation; and (3) downstream 
target gene activation. For the OSR, this involves: (1) Keap1 
modulation, (2) Nrf2 stabilization and nuclear transloca-
tion, followed by (3) target gene expression including Srxn1 
(Herpers et al. 2015; Mazur et al. 2010). The UPR involves 
(1) sensing of unfolded proteins in the lumen of the ER by 
BiP, IRE1, PERK and Atf6, followed by (2) downstream 
transcription factor stabilization and nuclear translocation 
of Atf4, ATF6 and Xbp1 and (3) subsequent activation of 
the expression of the chaperone BiP/GRP78/HSP5A and the 
transcription factor DDIT3/Chop (Takayanagi et al. 2013). 
Finally, the DDR involves (1) recognition of DNA damage 
sites and DNA damage foci formation with accumulation of, 
e.g., 53bp1 in these foci, (2) subsequent stabilization of p53 
through phosphorylation by kinases activated after DNA 
damage and (3) expression key p53 target genes upon trans-
location of p53 to the nucleus including p21 (CDKN1A) and 
Btg2 (d’Adda di Fagagna et al. 2003; Reinke and Lozano 
1997) (see Fig. 1a). We anticipate that the integration of 
all these different sensors, transcription factors and down-
stream targets in fluorescent protein reporters would facili-
tate the evaluation of the dynamic activation of adaptive 
stress responses at the single-cell level using high-content 
imaging approaches. Therefore, the aim of the current work 
was to establish and systematically evaluate the application 
of GFP reporters using HepG2 cell lines for these three piv-
otal adaptive stress response pathways using bacterial arti-
ficial chromosome (BAC) cloning technology (Poser et al. 
2008b), targeting individual ‘sensor’ proteins, transcription 
factors as well as downstream target proteins. Since DILI 
prediction remains a major problem, we focused on the 
integration of these reporters in the liver hepatoma cell line 
HepG2, which is routinely used for high throughput first tier 
liver toxicity liability assessment (Knasmuller et al. 2004; 
Lin and Will 2012; Maness et al. 1998).
Here, we established, characterized and evaluated in 
total eleven BAC-GFP HepG2 reporter cell lines reflect-
ing three adaptive stress response pathways for the appli-
cation in live cell high-content imaging in relation to a set 
of DILI reference compounds. Our data indicate that these 
reporter cell lines consistently and selectively monitor the 
dynamic activation of the OSR, UPR and DDR at the sin-
gle-cell level for pathway-specific compounds. Moreover, 
when we correlate the HepG2 BAC-GFP with activation of 
adaptive stress response in primary human hepatocytes we 
are able to identify the activation of these stress response 
pathways that are typically seen by DILI drugs in primary 
human hepatocytes. Interestingly, the live cell acquisition 
data allow the improved classification of DILI compounds 
based on dynamic stress pathway activation.
Results
GFP‑tagged stress‑reporter proteins respond 
to corresponding chemically induced stress
To enable live cell imaging of the chemically induced 
dynamics of cellular adaptive stress response programs, a 
panel of reporter cell lines was created using BAC cloning 
technology (Poser et al. 2008a). For each adaptive stress 
response pathway, an upstream ‘sensor,’ a transcription fac-
tor and a downstream target were chosen (Fig. 1a). For the 
oxidative stress response program (OSR), kelch-like ECH-
associated protein 1 (Keap1) was selected as upstream 
sensor, nuclear factor, erythroid 2-like 2 (Nrf2/NFE2L2) 
as transcription factor and Srxn1 as downstream target 
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(Herpers et al. 2015; Itoh et al. 2004). For the UPR, heat 
shock 70 kDa protein 5 (BiP/HSPA5) regulates the endo-
plasmic reticulum (ER)-stress/unfolded protein response 
(UPR) pathway through binding to accumulated unfolded 
proteins and consequently dissociating from the trans-
membrane transducers Atf6, PERK and IRE-1 (Hetz et al. 
2015); as such, BiP acts as a sensor of the UPR. However, 
BiP is also induced strongly after ER-stress (Gulow et al. 
2002) and also reflects UPR activation. We labeled two 
arms of the UPR: For the pro-survival route, we labeled 
the transcription factor Xbp1 and downstream target chap-
erone BiP; and for the translation inhibition and pro-apop-
totic arm, we labeled the activating transcription factor 4 
(Atf4) and DNA-damage-inducible transcript 3 (DDIT3/
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Fig. 1  Selection and characterization of adaptive stress response 
pathway markers for OSR, UPR and DDR. a Selection of the indi-
vidual reporters for the respective pathways representing ‘sensor,’ 
transcription factor and target genes. b Insertion of GFP into BAC 
plasmid is followed by transfection and selection of the (monoclo-
nal) HepG2 reporter. The selection process involves: (1) imaging of 
10–24 transfected HepG2 clones to determine suitability (fluores-
cence intensity and cell–cell variability) as a reporter cell line, with 
or without exposure to a stress-inducing compound depending on 
the reporter type, (2) determining the size of the target protein-GFP 
fusion and induction level after stress-inducing exposure by West-
ern blot. c Western blot analysis of reporter expression under control 
conditions and treatment conditions. Reporters for oxidative stress 
(Keap1, Nrf2 & Srxn1), ER-stress (Atf4, Xbp1, Chop & BiP), DNA 
damage (p53, p21 & Btg2). The size and responsiveness to chemi-
cal stress of the GFP-fusion protein product were evaluated. Cells 
were treated with 100 μM DEM (oxidative stress), 25 μM etoposide 
(DDR) and 1 μM thapsigargin (UPR) for the either 5 h (Nrf2-GFP) 
or 24 h (all others) followed by WB analysis. d Responsiveness of 
target genes was assessed by knock down for Nrf2 (Srxn1 activation), 
p53 (p21 and Btg2 activation) and UPR transcription factors Xbp1, 
Atf4 or Atf6 (BiP and Chop activation). Mock is the control condition 
transfected with transfection reagents, but without siRNA
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Chop). For the DNA damage response program (DDR), 
the upstream sensor tumor protein p53-binding protein 1 
(TP53BP1/53bp1) was chosen based on its ability to sense 
double-strand breaks (Lee et al. 2014) and activate the 
ataxia telangiectasia-mutated protein pathway (ATM). For 
the DDR, tumor protein p53 (TP53/p53) was chosen as the 
pivotal transcription factor; finally, the two p53 downstream 
targets cyclin-dependent kinase inhibitor 1 (CDKN1A/p21) 
and BTG family member 2 (Btg2) were selected. To ensure 
near-endogenous protein-fusion levels and normal regula-
tion of these adaptive stress response programs, enhanced 
green fluorescent protein (eGFP) and selection markers 
were cloned in bacterial artificial chromosome (BAC) vec-
tors, which consist of genomic DNA which still contain the 
endogenous promoter, enhancers and introns. BACs were 
selected that contained at least 10 kbp on either side of the 
exon domains.
The BAC-GFP constructs were created using homo-
logues recombination with pRed/ET recombinase, and 
these constructs were used to transfect HepG2 as described 
previously (Hendriks et al. 2012). Viable HepG2 colonies 
were passaged separately to obtain monoclonal BAC-GFP 
cell lines. For each target gene, a single monoclonal BAC-
GFP cell line was selected based on fluorescent intensity 
and protein size (Fig. 1b). All selected reporter lines were 
evaluated on fusion protein size, responsiveness to selec-
tive pathway activators and targeted knock down by RNAi 
(Fig. 1c, d). The GFP-tagged protein sizes for all targets 
with the exception of Nrf2 [which runs at 95 kDa instead 
of the theoretical 67 kDa as reported previously (Lau et al. 
2013)] were in line with reported values (http://www.gen-
ecards.org/). While Keap1-GFP levels were not induced 
by the pro-oxidant DEM, as expected, the levels of Nrf2-
GFP and Srxn1-GFP were clearly induced by DEM. The 
ER-stress reporters Atf4-GFP, Chop-GFP, Xbp1-GFP and 
BiP-GFP clearly responded to the ER-stress inducer thap-
sigargin. The DDR reporters p53-GFP, p21-GFP and Btg2-
GFP are clearly induced after 24-h exposure of the topoi-
somerase inhibitor etoposide; the large size of 53bp1-GFP 
(241 kDa) prohibited qualitative assessment by Western 
blotting.
Cellular localization of GFP-fusion products for all 
reporters was evaluated by confocal microscopy for control 
and compound treatment for 5 h (Nrf2) or 24 h (all others) 
(Fig. 2). A clear increase in levels of all downstream targets 
Srxn1-GFP, Btg2-GFP and BiP-GFP in the cytosol was 
seen. For the transcription factors Nrf2-GFP, Xbp1-GFP, 
Chop-GFP and p53-GFP as well as p21-GFP, an increase in 
nuclear intensity was observed. An increase in the number 
of nuclear DNA damage foci for 53bp1-GFP and cytosolic 
autophagosome-related foci for Keap1-GFP is also evident 
(autophagosomes co-localizes with p62 in immunofluores-
cent experiments, indicating autophagosomal location of 
Keap1-GFP (data not shown)). Little increase in Atf4-GFP 
was visible, yet image analysis revealed a clear and selec-
tive increase (see later Fig. 4).
Next for all individual BAC-GFP reporters, an auto-
mated multi-parameter imaging analysis pipeline was 
established using CellProfiler (Kamentsky et al. 2011) soft-
ware and ImageJ plug-ins (Fig. 3). Depending on the BAC-
GFP reporter type, the different imaging readouts were 
determined using automated image analysis. For 53bp1-
GFP and Keap1-GFP, we quantified foci formation in the 
cytosolic (Keap1-GFP translocation with autophagosomes) 
and nuclear compartment (53bp1-GFP localization in DNA 
damage foci), respectively. For Srxn1, BiP and Btg2, we 
quantified the integrated GFP intensity in the cytosol. For 
Nrf2, Xbp1, Atf4, Chop, p53 and p21, we determined the 
mean GFP intensity in the nucleus. The different quantita-
tive measurements reflect the altered expression and locali-
zation of our stress reporters.
Altogether, we have established a functional panel of 
adaptive stress response reporters that allow us to quantita-
tively assess the dynamic activation of individual pathway 
components in living cells at the single-cell level popula-
tion level.
Adaptive stress response BAC‑GFP reporters respond 
in a sensitive and selective manner to reference 
compounds
As a next step, we set out to test the responsiveness and 
selectivity of the panel of stress-reporter cell lines to: (1) 
oxidative stress-inducing agents DEM, CDDO-Met [a 
pharmacological inducer of Nrf2 activity, (Yang et al. 
2009)] and iodoacetamide (IAA); (2) DNA-damage-induc-
ing agents etoposide and cisplatin; and (3) UPR-inducing 
agents brefeldin A (BFA), tunicamycin (Tc) and thapsi-
gargin (Tg) (Supplemental Table 1). To monitor signaling 
programs well before any significant cytotoxicity occurs 
and, thereby, deduce causative relationships for the onset 
of cytotoxicity, compound concentrations were chosen that 
would not lead to significant cell death after 24 h as well as 
two additional concentrations that were twofold and four-
fold lower to assess the overall sensitivity of the reporter 
panel. Reporter cell lines were imaged for a period of 24 h 
using live cell confocal imaging and evaluated for onset of 
cytotoxicity by propidium iodide (PI) exclusion (Supple-
mental Fig. 1). Little cell death was observed, and no major 
differences between cell lines were discernable.
We set out to obtain mechanistic information on the 
mode of activation of our different reporters and antici-
pated a selective activation by our reference compounds. 
We first evaluated whether, as a simplified method, only 
the final time point of the live imaging dataset would be 
sufficient to determine reporter activation. The endpoints 
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from the different quantitative features of each reporter (see 
Fig. 3) were collected for each reference compound con-
centration range and subjected to an unsupervised hierar-
chical clustering (Pearson distance method and Ward clus-
tering) and displayed as a heatmap (Fig. 4). The heatmap 
showed a clear clustering of the reporter cell lines and ref-
erence compound groups within the corresponding adap-
tive stress response pathway. This was reflected by a sig-
nificant activation of the GFP reporters. Intriguingly, at this 
24-h time point Nrf2-GFP did not show enhanced nuclear 
localization and for any of the reference compounds, pos-
sibly related to an earlier activation. The DNA damage 
and UPR reporters were all activated by their correspond-
ing reference compound sets. Interestingly, the UPR ref-
erence compound thapsigargin also strongly activated the 
oxidative stress reporters Keap1 and Srxn1, in accordance 
with observations in neuronal cells (Li and Hu 2015), yet 
brefeldin A and tunicamycin selectively induced the UPR 
response. Brefeldin A slightly activated the 53bp1-GFP 
reporter, while the p53-GFP, Btg2-GFP and p21-GFP were 
not activated. This underscores the possibility to identify 
compound-specific responses.
Live cell imaging of HepG2 reporters defines temporal 
ranked adaptive stress response profile
We obtained detailed live cell imaging data over a 24-h 
time course for the entire reference dataset. Next, we inves-
tigated whether live cell imaging adds value in quantify-
ing adaptive stress response programs. For most reference 
compounds, reporter activation occurred within the first 
hours after treatment, dependent on the reporter (Fig. 5). 
Also, the dynamics of the response differed per reference 
compound and reporter. Thus, the live cell data demon-
strate a rapid accumulation of Nrf2-GFP starting around 
2 h and returning to close to baseline levels after 15 h for 
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OSR: Keap1, Nrf2 and Srxn1 (a); UPR: BiP, Xbp1, Atf4 and Chop 
(b), and DDR: 53bp1, p53, p21 and Btg2 (c). Two left columns reflect 
vehicle treatment for 24 or 5 h for Nrf2 (left column overall image; 
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the reporters Keap1 and 53bp1 require a higher resolution to be able 
to count the number of foci per cell, and as such these were captured 
at 40× magnification on 1024 × 1024 pixels. Hoechst channel is 
omitted for low intensity-level reporters in the right columns (zoom) 
panel
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CDDO-Me, DEM as well as IAA (Fig. 5). IAA exposure 
caused early activation of several adaptive stress response 
programs: the OSR reporters Keap1, Nrf2 and Srxn1 but 
also UPR reporter Xbp1 and DDR reporter 53bp1. Inter-
estingly, while thapsigargin showed strong activation of all 
UPR reporters as well as the Keap1 and Srxn1 reporter, no 
clear stabilization of Nrf2-GFP was observed. Next, the 
entire set of quantitative time course data of the reference 
compounds for all reporters was subjected to cubic hier-
archical clustering (maximum distance measure and com-
plete linkage clustering), thus taking into consideration 
the time dynamics of each reporter–treatment combina-
tion. The reporter and treatment stress types again cluster 
fully together (Fig. 6). However, by inclusion of the time 
Fig. 3  Automated image 
analysis of BAC-GFP reporter 
cell lines. Automated imaged 
analysis was performed using 
CellProfiler and ImageJ-based 
algorithms as described in 
“Materials and methods” 
section. a The Keap1 and 
53bp1 reporters were based 
on foci detection. Left panel: 
A 1024 × 1024 pixel 40 times 
magnified image of Keap1-GFP 
reporter after 24-h exposure to 
100 μM DEM. Blue staining 
corresponds to the nuclei (i) 
and green corresponds to the 
Keap1-GFP-fusion protein 
(iii). The nuclei are segmented 
(ii) and used as seeds for the 
cytosol identification using the 
GFP signal (iv), the outlines of 
the nuclei and cytosols are dis-
played as yellow lines. Next, the 
GFP-signal foci corresponding 
to Keap1-GFP being degraded 
in autophagosomes are seg-
mented (v) and assigned to indi-
vidual cells. b The Btg2, Srxn1 
and BiP reporters are based on 
quantifying the GFP signal in 
the cytosolic region of cells. 
First, the nuclei signal (i) is 
segmented (ii) and used as seeds 
for the cytosol identification (iii, 
iv). c The p21, p53, Nrf2, Xbp1, 
Atf4 and Chop reporters are 
based on quantifying the GFP 
signal in the nuclei. The nuclei 
signal (i) is segmented (ii), and 
these regions (iv) are directly 
used to quantify the GFP inten-
sity (iii) (color figure online)
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dynamics into the clustering algorithm compounds with 
similar time dynamics cluster together within the refer-
ence and model compound blocks and thus reveals distinct 
response-type sub-clusters. This is most evident as the 
different compounds induce responses with distinct time 
dynamics, and therefore, the concentration ranges for each 
compound cluster together, in contrast to the endpoint clus-
tering of Fig. 4. Altogether, this supports the notion that 
the entire time course dynamics of compound responses on 
reporter cell lines provides added value for classification of 
compounds.
DILI compounds mainly activate OSR and UPR 
reporter genes in primary human hepatocytes (PHH)
As a next step, we set out to test the reporter platform in 
a more DILI-relevant setting. To assess the correlation 
between adaptive stress pathway activation in PHH and that 
observed in our BAC-GFP reporters, we decided to focus 
on four downstream targets that showed the most promi-
nent responses in PHH: OSR, Srxn1; UPR, Chop and BiP; 
DDR, p21. First, we calculated the log2 fold changes for all 
DILI compounds from the PHH data from the TG-GATES 
dataset for all our 11 reporter genes. We next subjected 
these data to hierarchical clustering (Fig. 7a). The oxidative 
Fig. 5  Dynamic GFP reporter activation for different adaptive stress 
response pathways. a Representative images of the dynamic acti-
vation of the various stress response pathway reporter cell lines by 
different reference model compounds: OSR, DEM; UPR, Tg; DDR, 
Etop). b Time dynamics of all reference compounds on the differ-
ent stress response reporters. Data shown are the normalized values 
for individual reporters. Different colors indicate low (red), medium 
(green) and high (blue) concentrations. Significance is depicted as 
*p < 0.05, **p < 0.01 and *** p < 0.001 (color figure online)
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Fig. 6  Cubic hierarchical clustering of the time courses of the 
reporter panel and reference compounds. Time dynamics of all refer-
ence compounds on the different stress response reporters was used 
for cubic hierarchical clustering as described in “Materials and meth-
ods” section. Data shown are the normalized values for individual 
reporters of >3 independent experiments
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stress transcript levels were increased by a set of 39 com-
pounds with NFE2L2, KEAP1 and SRXN1 correlation over 
all treatments being high (Pearson correlation KEAP1-
NFE2L2 0.64, KEAP1-SRXN1 0.58, NFE2L2-SRXN1 
0.45). The transcript-level responses of the UPR genes 
were diverse; 53 compounds activated the DDIT3 of which 
33 (62 %) negatively regulated HSPA5. ATF4 seemed to 
slightly correlate with oxidative stress (Pearson correlation 
SRXN1-ATF4 0.4). Hardly any changes in transcript levels 
of XBP1 were seen likely due to its mechanism of posttran-
scriptional regulation (Yoshida 2007).
A very small number of DILI compounds affected TP53, 
TP53BP1, CDKN1A or BTG2 transcript levels in PHH; this 
reflects the thorough screening for DNA damage effects 
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Fig. 7  Primary human hepatocyte data from TG-GATES. a Unsuper-
vised hierarchical clustering of log2 fold-change values of primary 
human hepatocyte transcripts in PHH. b Rank-ordered transcript fold 
changes for each reporter gene. Top 10 upregulated compounds per 
reporter gene are displayed on the right
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of pharmaceuticals. A small cluster of compounds acti-
vated the CDKN1A and BTG2 expression but not TP53 and 
TP53BP1.
To select a set of DILI compounds that selectively 
affects individual reporters, we rank-ordered the PHH fold-
change transcript-level data for Srxn1, Chop, BiP and p21 
and selected 10 compounds that originate from the top 12 
ranked compounds as DILI-compound test set (Fig. 7b), in 
total resulting in 29 different DILI compounds that partly 
had overlap between downstream targets.
HepG2 reporters define temporal ranked adaptive 
stress response profiles of DILI‑relevant compounds
Next, we tested the 29 DILI compounds in the Srxn1-GFP, 
Chop-GFP, BiP-GFP and p21-GFP cell line. For compara-
tive purposes, the same concentrations were used as in the 
PHH TG-GATES high-dose data. All four reporter cell lines 
were imaged live for 24 h (Supplemental Fig. 2). The result-
ant reporter–response time courses were subjected to the 
same cubic hierarchical clustering, which led to several dis-
tinct clusters of response types (Fig. 8). Different response 
types were defined based on the intensity of the response, 
the response type and the order of the response types. 
Based on the Srxn1-intensity level, clusters of no induc-
tion (S-0), weak induction (S-1), middle induction (S-2) 
and strong induction (S-3) can be defined. The S-0 group of 
compounds includes a set of 7 treatments, which are nega-
tive among all 4 reporters. The remaining S-0 treatments 
showed a weak p21 activation. The S-1 cluster of slightly 
increased Srxn1 levels is preceded by p21 activation, and in 
the case of cyclosporin A BiP-GFP levels increased mark-
edly in time preceding Srxn1-GFP activation. Within the 
strong Srxn1 activation cluster (S-3), a subset of treatments 
oxidative stress co-occurred with p21 as well, most notably 
etoposide and colchicine. A distinct adaptive stress response 
profile was related to strong Chop-GFP induction by 
tacrine, omeprazole and thioridazine. However, no increase 
in BiP-GFP chaperone is evident, in contrast to azathioprine 
and sulindac, which have a low Chop-GFP activation, but a 
strong BiP-GFP activation. Finally, we assessed the positive 
co-occurrence of reporter gene activation between reporter 
transcript levels in PHH and GFP reporter levels in the four 
reporter cell lines. The correlation was 9/10 for Srxn1-GFP, 
6/10 for p21-GFP and 2/10 for Chop-GFP and 2/10 for BiP-
GFP (Supplementary Fig. 2).
Discussion
In the current study, we established a panel of fluores-
cent protein reporter HepG2 cell lines using BAC clon-
ing technology to follow the dynamics of several adaptive 
stress response pathways essential in chemical-induced 
cytotoxicity. We focused on target genes that are central 
in the regulation of three key adaptive stress response 
programs; for each pathway, we successfully established 
reporters for the sensory machinery, downstream tran-
scription factor and one of the transcription factors down-
stream targets. Our results show that the adaptive stress 
response reporters are selective and sensitive to their cor-
responding reference training compounds. Moreover, live 
cell imaging enabled us to define the temporal order of 
activation of the adaptive stress response programs initi-
ated after chemical exposure. Furthermore, DILI-related 
compounds that are strong inducers of our selected adap-
tive stress response pathways in PHH were positively 
identified in the HepG2 reporter cell models with Srxn1, 
Chop and p21.
Monitoring of adaptive stress response pathways as a 
predictive tool for chemical safety prediction has gained 
considerable attention in systems toxicology (Jennings 
et al. 2013; Wink et al. 2014). So far the approaches have 
largely been used as transcriptomic-based strategies (Jen-
nings et al. 2013; Limonciel et al. 2015). Transcriptom-
ics provides a comprehensive analysis to monitor cellular 
stress responses to chemicals at a single time point and 
average population level. The application of our GFP-based 
reporter cell lines as presented here, in conjunction with 
high-content live cell imaging, provides various advance-
ments in chemical safety assessment that are not feasible 
with and/or complementary to transcriptomics. Firstly, we 
now can quantitatively assess the regulation of the entire 
adaptive stress response pathway irrespective of transcrip-
tional regulation. Thus, we can monitor the modulation of 
upstream regulators such as Keap1 and 53bp1, which are 
constitutively expressed and translocate to the autophago-
somes and DNA damage foci, respectively, upon activa-
tion. Moreover, we can observe posttranslational regula-
tion of reporter expression of in particular transcription 
factors due to protein stabilization, e.g., Nrf2, or p53, or 
alternative processing of mRNA (e.g., Xbp1). Secondly, 
our GFP-based reporters allow a more mechanistic evalu-
ation of the relationship between stress pathway activation 
and cytotoxicity since we can follow the onset of stress 
responses at the real protein expression level, the cell 
physiology-relevant molecules in cells, in single cells with 
the subsequent assessment of cell viability (e.g., onset of 
necrosis or apoptosis). Thirdly, it is more cost- and tech-
nically feasible to monitor the response in a high time 
resolution to determine temporal orders of stress pathway 
activation. It is of critical importance to define the detailed 
oscillatory dynamics from, e.g., NF-κB (Fredriksson et al. 
2014) that are generally controlled by genetically defined 
negative feedback loops. Fourthly, the GFP reporters allow 
the possibility to assess the overall cell and cell organelle 
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morphological perturbations as well as foci formation 
from, e.g., autophagosomes or DDR repair foci (Wink et al. 
2014).
In comparison with previous high-content imaging stud-
ies, to our knowledge we developed the first high-content 
imaging assay able to monitor the response of cells to 
chemical exposure on a signaling level. Previous high-con-
tent imaging studies were based on either cytotoxic param-
eters such as cell death, ROS, mitochondrial potential and 
Ca2+-based dyes which measure toxic outcome measures 
and not the cellular responses that combat these adversities, 
or morphological features which capture morphological 
changes of cells or organelles and correlate these indirectly 
to mechanisms or classify morphology-based perturba-
tions due to chemical exposure with the use of training data 
(Garside et al. 2014; Loo et al. 2007; Persson et al. 2013).
Our data indicate that our BAC-GFP-based reporter 
approach can clearly reveal subtle differences in the mode 
of action of compounds. Our UPR reference compounds 
thapsigargin and tunicamycin both induced the onset of two 
key UPR reporters, e.g., Chop-GFP and BiP-GFP, to a sim-
ilar extent and with a similar temporal profile (see Fig. 5). 
Yet, while thapsigargin also induced a strong induction 
of the Srxn1 reporter, tunicamycin did not. Thapsigargin 
causes ER-stress due to its inhibition of the SARC/ER Ca2+ 
ATPase, thereby lowering Ca2+ levels in the lumen of the 
ER. Tunicamycin blocks protein glycosylation in the ER. 
While both conditions initiate the UPR response, ER cal-
cium perturbations also induce an oxidative stress response. 
Yet, the latter response is different from compounds that 
directly target protein thiols, including iodoacetamide and 
DEM; although thapsigargin caused Keap1-GFP foci for-
mation, this was not associated with a strong accumula-
tion of Nrf2-GFP, which is observed with iodoacetamide 
and DEM. These results clearly illustrate the strength of 
the temporal single-cell live cell analysis of adaptive stress 
responses for mode-of-action clarification. Likewise, such 
reporter systems may also contribute to the adverse out-
come pathway (AOP) toolbox and as such quantify the acti-
vation of individual key events that reflect and are critical 
in toxicological-relevant AOPs (Ankley et al. 2010).
An important asset of our reporter systems is the tem-
poral information on the activation of cellular defense pro-
grams after toxicological insult. This allows the definition 
of a detailed stress-response fingerprint for individual 
compounds. Since our method also marks the onset of cell 
death, this would include the identification of a point-of-
no-return or tipping point, reflecting both the concentra-
tion and time point after which a certain fraction of cells 
dies because the defensive programs cannot cope with the 
level of stress induced by the toxicant. Together, the acti-
vation of certain adaptive stress response programs, the 
order of activation of these programs, the concentration 
or time after which the tipping point is reached will be of 
great benefit for risk assessment early in the toxicity test-
ing pipeline and for realization of more mechanistically 
defined AOPs.
An important feature of our reporter cell systems is that 
we can detect DILI compound stress responses that are 
observed in primary human hepatocytes. For a proof of con-
cept, we concentrated on four downstream target genes for 
oxidative stress (Srxn1), UPR (BiP, Chop) and DDR (p21). 
We observed a strong concordance for in particular Srxn1-
GFP and p21-GFP reporters and a reduced concordance 
for the BiP-GFP and Chop-GFP reporters. This suggests 
that our HepG2 reporter models translate well to responses 
in PHH. This is in particular of interest since the PHH 
responses were based on transcriptomics and not protein 
expression. Our finding would be in agreement with recent 
observations that the onset of cytotoxicity caused by a broad 
set of DILI compounds is comparable between HepG2 and 
PHH (Park and Goldring, personal communication). Dis-
crepancies between PHH and HepG2 reporters could be 
due to this difference, since it is established that the corre-
lation between transcriptomics and proteomics in the same 
model does not correlate well. Alternatively, ADME and/or 
cell physiological differences between HepG2 reporters and 
PHH could explain the differences. The Srxn1-GFP reporter 
showed the highest concordance with PHH, also suggesting 
a conservation of the Keap1/Nrf2/Srxn1 pathway activation 
in HepG2 cells compared to PHH.
We have established our reporters in HepG2 cells. The 
adaptive stress response pathways that we have incor-
porated in these cells are not specific to liver cells and 
involved in the regulation of toxicity in most if not all cells 
in the body, albeit most likely with different set points. As 
such, our HepG2 reporters could be representative for gen-
eral toxicity. Induced pluripotent stem cell technology in 
combination with genetic recombineering strategies will 
allow the integration of the GFP reporters in iPSC followed 
by the differentiation in any cell type. This would open the 
way for the assessment of the adaptive stress pathway acti-
vation in any differentiated cell type as well as the precise 
quantitative understanding of the differences in control and 
activation between the various cell types in a same genetic 
background.
Fig. 8  Effect of selected DILI test compounds on stress response acti-
vation. DILI compound selection origin is labeled black (left legend), 
24-h time course corresponds to the 4 individual columns, each col-
umn representing a time course for 1 of 4 reporter cell lines. Response 
magnitude is labeled as orange intensity and according to the legend 
(top right). Compounds and concentrations are displayed as rows and 
labeled on the right. The time course profiles were subjected to cubic 
clustering as described in “Materials and methods” section (color fig-
ure online)
◂
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In conclusion, we established a robust high throughput 
imaging-based platform for the single-cell assessment of 
adaptive stress response pathway activation in a tempo-
ral fashion. This platform can contribute to a mechanism-
based chemical safety assessment in both an industry and 
regulatory setting.
Materials and methods
Reagents
All compound drugs were acquired from Sigma-Aldrich, 
except for cisplatin (Ebewe), CDDO-Me (kind gift from 
Dr. Ian Copple, University of Liverpool), bendazac (kind 
gift from Dr. Anita Dankers, Janssen Pharmaceutics), met-
formin (MIP DILI consortium), propylthiouracil, captopril, 
tacrine, thioridazine, azathioprine and sulindac (all a kind 
gift from Dr. Weida Tong, NCTR-FDA). All compounds 
were freshly dissolved in DMSO, except for metformin, 
venlafaxine, methapyrilene, fluphenazine, buthionine sul-
foximine, bromoethylamine, lomustine (all PBS), acetami-
nophen, 2,4-dinitrophenol and phenobarbital (all DMEM).
Cell culture
Human hepatoma HepG2 cells were acquired from ATCC 
(clone HB8065) and maintained and exposed to drugs in 
DMEM high glucose supplemented with 10 % (v/v) FBS, 
25U/mL penicillin and 25 μg/mL streptomycin. The cells 
were used between passage 5 and 20. For live cell imaging, 
the cells were seeded in Greiner black μ-clear 384 wells 
plates, at 20,000 cells per well.
Generation of GFP‑tagged cell lines
Human KEAP1, NFE2L2 (Nrf2), CDKN1A (p21), TP53 
(p53), BTG2, TP53BP1 (53bp1), XBP1, DDIT3 (Chop), 
ATF4, HSPA5 (BiP) and mouse SRXN1 BAC clones were 
selected and GFP-tagged as described previously (Poser 
et al. 2008b) and stably introduced into HepG2 cells by 
transfection and 500 μg/ml G-418 selection. At least 20 
of the monoclonal BAC-transfected HepG2 colonies were 
separately grown out, and GFP-positive clones suitable for 
imaging were selected to complement the BAC-GFP stress 
response reporter platform.
RNA interference
siRNAs against human NFE2L2 (NRF2), TP53 (P53), 
ATF4, ATF6 and EIF2AK3 (PERK) were acquired from 
Dharmacon (Thermo Fisher Scientific) as siGENOME 
SMARTpool reagents, as well as in the form of four 
individual siRNAs. HepG2 cells were transiently trans-
fected with the siRNAs (50 nM) using INTERFERin (Poly-
plus) as described previously (Fredriksson et al. 2011).
Western blotting
Samples were collected by direct cell lysis (including pel-
leted apoptotic cells) in 1× sample buffer supplemented 
with 5 % v/v β-mercaptoethanol and heat-denatured at 
95 °C for 10 min. The separated proteins were blotted 
onto PVDF membranes before antibody incubation in 
1 % BSA in TBS-Tween20. Antibodies: mouse-anti-GFP 
(Roche) and mouse-anti-tubulin (Sigma) and mouse-anti-
GAPDH (Santa Cruz), all antibodies were diluted 1000 
times. Horseradish peroxidase detection was performed 
by Pierce® ECL (Thermo Scientific) using the Image-
Quant LAS4000 (GE HealthCare). Cy5 was detected by the 
ImageQuant LAS4000 (GE HealthCare).
Microscopy
Accumulation of target protein-GFP levels, localization or 
foci formation and propidium iodide staining was moni-
tored using a Nikon TiE2000 confocal laser microscope 
(lasers: 561, 488 and 408 nm), equipped with an automated 
stage and perfect focus system. Prior to imaging at 20× 
magnification and either 1X, 2X or 4X zoom, HepG2 cells 
were loaded for 45 min with 100 ng/mL Hoechst 33342 to 
visualize the nuclei, upon which the Hoechst-containing 
medium was washed away to avoid Hoechst phototoxicity 
(Purschke et al. 2010). After Hoechst-33342 staining, com-
pound exposure was conducted, followed by automated 
24-h live cell confocal imaging. The time interval was 
dependent on the required resolution for the corresponding 
reporter cell line and on the number of reporter types plated 
simultaneously on the imaging plates. Cell death was deter-
mined by monitoring the accumulation of PI stained cells 
after a 24-h time period.
Quantitative image analysis
Image quantification was performed with CellProfiler ver-
sion 2.1.1 (Kamentsky et al. 2011) with an in-house devel-
oped module implementing the watershed masked algorithm 
for segmentation (Di et al. 2012). The watershed separates 
an image in regions with single cells followed by pixel clas-
sification for each region as fore- or background, and this 
method performs well detecting the Hoechst33342 stained 
nuclei of the closely packed HepG2 cells. The binary mask 
containing the segmented nuclei was fed to the identify-
primary-objects module, overlap-based-tracking module 
and intensity-nuclei-size-shape-measurement modules of 
CellProfiler. For the cytosol location of the Srxn1-GFP, 
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Btg2-GFP and BiP-GFP reporters, the nuclear objects were 
used as seeds for the identify-secondary-objects module set 
to a propagation method with the MCT algorithm on adap-
tive (window size approximately 20 pixels) segmentation. 
The Keap1-GFP and 53bp1-GFP reporters are based on foci 
detection. The nuclei are segmented and used as seeds for 
the cytosol identification using the cytosolic GFP signal for 
the Keap1-GFP cell line. The foci detection is performed 
with the FociPicker3D plug-in (Du et al. 2011) in ImageJ, 
and each individual focus is assigned to either the nuclei (for 
53bp1) or cytosol (Keap1) using the CellProfiler assign par-
ent–child relationship module. The p21, p53, Nrf2, Xbp1, 
Atf4 and Chop reporters are based on quantifying the GFP 
signal in the nuclei. The nuclei signal is segmented, and 
these regions are directly used to quantify the GFP intensity. 
Segmentation results were stored as PNG files for quality 
control purposes, and CellProfiler pipelines were stored for 
reproducibility. Image analysis results were stored on the 
local machine as HDF5 files.
Data analysis
Data analysis, quality control and graphics were performed 
using the in-house developed R package H5CellProfiler 
(Wink, manuscript in preparation). The features of interest 
were extracted from the HDF5 files and further analyzed 
using the graphical user interface of the H5CellProfiler 
package. The mean of single-cell features for each com-
pound, concentration, cell line and replicate combination 
was calculated. To account for PI background staining and 
noise, the segmented PI segmentations were masked by a 
2 pixel dilated nuclei. The area of these nuclei and the PI 
were divided to obtain the cell death stain to cell area ratio. 
These ratios were filtered to be at least 10 % of the cell size, 
and following this procedure, each cell was either flagged as 
alive or dead in the final time point of the 24 live imaging 
sessions. In this manner, the fraction of dead cells could be 
accurately determined. All resultant summarized data were 
stored as tab-delimited text files and further processed for 
normalization and graphical presentation using R.
Scaling and plate normalization
For model compound dataset, the different imaging meas-
ures were standardized by scaling (i.e., mean or sum of 
intensity measures, foci counts), and scaling was used for 
each plate—cell line combination:
For the DILI compound dataset, the fraction of GFP-posi-
tive cells was determined to increase sensitivity of the assay. 
A GFP-positive cell was defined as minimally twice the 
xscaled =
x − xmin
xmax − xmin
DMSO—control background level. No scaling was used 
for the GFP-positive fraction measures. The total imaging 
time and time intervals for the different plates and repli-
cates varied; thus, for statistical analysis and plate normali-
zation regression was performed using the ‘lm’ function of 
the ‘stats’ package. Natural spline regression with 6 degrees 
of freedom was performed using the ‘ns’ function of the 
‘splines’ package. The additional linear constraints of the 
natural spline algorithm at the predictor boundaries allowed 
a stable extrapolation of the total time to equal length for all 
plates. Twenty-four equidistant time points for each condi-
tion were sampled from the model and subjected to quantile 
normalization to equalize the distributions for each plate.
Statistical analysis
The quantile normalized data were subjected to statistical 
significance tests with the following set of formulae; the 
mean over the replicates for the DMSO controls for each 
reporter rp and time point tp:
The difference x_diff between the DMSO means 
and treatments normalized with standard errors at each 
reporter rp, treatment tr and time point tp. With the stand-
ard errors:
The standard error over the replicates of the DMSO con-
trols, for each reporter and time point:
The standard error over the replicates, for each reporter, 
treatment and time point:
The mean residual standard error, with resid the residu-
als from the regression, for each replicate, reporter and 
treatment. This ensures the variance from the raw data is 
included in the statistical analysis.
Finally, for each replicate, reporter and treatment, the 
mean difference over time meanDiff is calculated:
x¯DMSO(rp, tp) =
1
repl
repl∑
r=1
xDMSO(rp, tp)
xdiff(repl, rp, tr, tp) =
x − x¯DMSO√
σ 2DMSO + σ
2
DMSO,resid + σ
2
tr + σ
2
tr,resid
σxDMSO(rp, tp) = sd(xDMSO(rp, tp))
σx(rp, tr, tp) = sd(x(rp, tr, tp))
σ
xˆ,resid(repl, rp, tr) =
√(∑
tp (resid(repl, rp, tr ))2
dftp − 1
)
xmeanDiff(repl, rp, tr) =
1
tp
tp∑
tp=1
x(repl, rp, tr)
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A two-sample one-sided Student’s t tests between the 
meanDiff values of matched DMSO control replicates and 
treatment replicates were performed. A one-sided test was 
chosen as we are only interested in positive responses with 
respect to our DMSO controls. To control for the p value 
gained by using a one-sided test, all p values were multi-
plied by 2.
In summary, the average and standard error for each 
point in time of the quantile normalized values were cal-
culated over the replicates for DMSO. The distance of the 
treatments to the DMSO mean at each point was determined 
and normalized by four standard error terms; the standard 
error of the treatment replicates, the DMSO replicates and 
the mean residual standard error of the regression analysis 
for the treatments and controls. The mean difference over 
time was calculated, followed by a one-sided Student’s t test 
to determine whether the replicate treatment curves were 
significantly different in the positive direction compared to 
the DMSO control replicates.
Cluster analysis
Cluster analysis was performed using the ‘dist’ and ‘hclust’ 
functions from the ‘stats’ package from the base R distri-
bution. For all cluster analysis, the distance metric was 
‘euclidean’ and clustering algorithm ‘complete.’ The clus-
tering of the time curve data required clustering of an 
extra dimension (time). All pairwise time curve distances 
were computed. The mean distances per compound–com-
pound and reporter–reporter combinations were calculated, 
reduced the dimensions to 2 and used as input for the clus-
tering algorithm.
Data representation
All HCI data representations were generated or modi-
fied with Illustrator CS6, Fiji, ggplot2 (Wickham 2009), 
the aheatmap function of the NMF package (Gaujoux and 
Seoighe 2010). For response data clustering, the equidistant 
sample time profile features from the b-spline model were 
used to calculate a distance matrix for each feature sepa-
rately using Euclidean distance. A mean distances matrix 
was calculated and subjected to clustering with the ward.D 
method of the hclust function.
Gene expression analysis
CEL files were downloaded from the Open TG-GATEs 
database: ‘Toxicogenomics Project and Toxicogenomics 
Informatics Project under CC Attribution-Share Alike 2.1 
Japan’ http://dbarchive.biosciencedbc.jp/en/open-tggates/
desc.html. Probe annotation was performed using the 
hthgu133pluspmhsentrezg.db package version 17.1.0, 
and Probe mapping was performed with hthgu133plusp-
mhsentrezgcdf downloaded from NuGO (http://nmg-r.
bioinformatics.nl/NuGO_R.html). Probe-wise back-
ground correction (Robust Multi-Array Average expres-
sion measure), between-array normalization within each 
treatment group (quantile normalization) and probe set 
summaries (median polish algorithm) were calculated 
with the rma function of the Affy package (Affy package, 
version 1.38.1 (Irizarry et al. 2003). The normalized data 
were statistically analyzed for differential gene expression 
using a linear model with coefficients for each experi-
mental group within a treatment group. (Smyth 2004; 
Wolfinger et al. 2001). A contrast analysis was applied to 
compare each exposure with the corresponding vehicle 
control. For hypothesis testing, the empirical Bayes sta-
tistics for differential expression was used followed by an 
implementation of the multiple testing correction of Ben-
jamini and Hochberg (1995) using the LIMMA package 
(Smyth 2004).
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